Inactive Instrument

Other languages Apricus Biosciences Inc Nasdaq

Equities

US03832V3078

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected	Mar. 19
Seelos Therapeutics' ALS treatment fails in mid-stage study	Mar. 19
Seelos Therapeutics, Inc. Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis Study with SLS-005 (IV Trehalose)	Mar. 19
Seelos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06
Singapore Stocks Open on Monday in Red; IX Biopharma’s Stock Plunge 9% Following Contract Termination	Mar. 04
IX Biopharma’s Subsidiary Issues Termination Notice for Licensing Agreement; Shares Plunge 9%	Mar. 03
Seelos Therapeutics Launches Registered Direct Offering, Concurrent Private Placement	Jan. 26
Seelos Therapeutics, Inc. Announces Receipt of Minutes from its End of Phase II Meeting with the United States Food and Drug Administration Highlighting Modifications to the Primary and Secondary Endpoints of its Phase II Study of SLS-002	Jan. 22
Sector Update: Health Care Stocks Gain Premarket Tuesday	Dec. 19
Seelos Therapeutics Files $250 Million Mixed Shelf	Dec. 19
Seelos Therapeutics Insider Bought Shares Worth $100,223, According to a Recent SEC Filing	Dec. 01
Sector Update: Health Care Stocks Mixed Late Afternoon	Nov. 29
Sector Update: Health Care	Nov. 29
Top Midday Decliners	Nov. 29
Top Premarket Decliners	Nov. 29
Seelos Therapeutics Prices Common Stock Offering	Nov. 29
Seelos Therapeutics Commences Common Stock Offering	Nov. 28
Seelos Therapeutics, Inc. Announces the Selection of SLS-002 (intranasal Racemic Ketamine) for Inclusion in the U.S. Department of Defense's Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder	Nov. 27
Top Decliners	Nov. 24
Sector Update: Health Care Stocks Higher Friday Afternoon	Nov. 24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Apricus Biosciences Inc Nasdaq

Equities

US03832V3078

Other languages

Filters